Henry Mahncke

Oct 25, 2024 | psychologytoday.com | Michael Merzenich |Michael Merzenich Ph.D |Henry Mahncke

By Michael Merzenich, Ph.D. and Henry Mahncke, Ph.D.Next weekend, almost all of us in the United States and Canada will engage in that semi-annual ritual of adjusting our clocks by an hour. However, we are not just messing with our clocks. To some extent, we are messing with our brains.

Oct 21, 2024 | psychologytoday.com | Michael Merzenich |Henry Mahncke |Michael Merzenich Ph.D

By Michael Merzenich, Ph.D., and Henry Mahncke, Ph.D.We are in a season of fear. We are facing election fears just five days after Halloween. The quadrennial political election has become a quadrennial battle that seemingly threatens our existence. People ask: What’s going on in our brains? Why do we experience so much fear? The simple answer: Scary stuff activates the brain. When you encounter scary stuff, the brain kicks in—with vigor—to figure out survival.

Aug 1, 2024 | forbes.com | Henry Mahncke

CEO of Posit Science, developers of the BrainHQ brain training program. Focused on digital health and bringing science to the people. Receiving a diagnosis of Alzheimer’s is one of the scariest pieces of news a person can face. While other medical diagnoses carry bad news for your health (e.g., cancer, heart disease or diabetes), a diagnosis of Alzheimer’s poses a unique threat to a person’s sense of self.

May 30, 2024 | inbusinessphx.com | Henry Mahncke |Benjamin Little

Those who are at a digital health startup face a challenge other types of software companies rarely face — they have to prove their software actually works. Other software may launch with a minimally viable product that sort of works, but those who want to sell into healthcare need to convince experts the app delivers expected benefits. For instance, a sleep app would be expected to have data it improves sleep or a weight-loss app have data showing users lose weight.

May 23, 2024 | thetonic.ca | Henry Mahncke |Jamie Bussin

The Long Term Effects Of Taking The DrugBy Dr. Henry Mahncke and Jamie BussinWe know that Ozempic, and other GLP-1 agonist drugs are effective at maintaining blood sugar levels for those with Type 2 diabetes and for those trying to lose weight. But do we know how these drugs actually work? I interviewed brain scientist Dr. Henry Mahncke recently on episode #327 of The Tonic Talk Show/Podcast. This article is a digest of our discussion.